Core Insights - JD Health hosted the first "Scientific Liver Protection, Healthy Future" industry forum, releasing the "2025 Scientific Liver Protection Consumer Insight Report" in collaboration with Zhongkang Technology [1] Market Trends - The report indicates that liver protection drugs are characterized by high average transaction value and high repurchase frequency, driving continuous market expansion [1] - JD Health's data shows that the sales growth rate of liver protection drugs is expected to reach 26% year-on-year in 2024 [1] Consumer Behavior - Patients spend an average of over 1800 yuan annually on liver protection drugs, with an average transaction value exceeding 260 yuan [1] - The repurchase rate for these drugs is over 50%, with an average of nearly 7 repurchases per year per patient [1] Online Consultation Growth - JD Internet Hospital reports a significant increase in online consultations for liver diseases, with a growth rate exceeding 67% from Q2 2024 to Q2 2025 [1] Strategic Goals - JD Health aims to leverage its platform capabilities and resources to focus on early screening, prevention, and treatment of liver diseases, collaborating with partners to build a more comprehensive disease prevention and patient service system [1]

Core Insights - The "2025 Scientific Liver Health Consumption Insight Report" was released at the "Scientific Liver Protection, Healthy Future" industry forum hosted by JD Health, highlighting the increasing prevalence of liver diseases among younger populations due to unhealthy lifestyle habits [1] - The report indicates that liver disease patients constitute the largest group (35%), primarily middle-aged men, but exhibit low compliance; other segments include "Liver Health Pioneers" (22.6%), "Hangover Experts" (21.1%), "Night Owls" (13.3%), and "Chronic Disease Guardians" (8%) [1] - Despite a strong demand for liver health products, consumers face confusion regarding product effectiveness, with 47.5% struggling to assess product results and a satisfaction rate of only 69.6% for health supplements [1] - The rise of online channels and internet healthcare is providing solutions to these issues, with OTC liver health products showing a repurchase rate exceeding 50% and online consultations becoming a convenient option for consumers [1] Industry Recommendations - Dr. Yan Jie from the Capital Medical University Affiliated Beijing Ditan Hospital emphasizes the importance of "early screening, early intervention, and early treatment" for liver disease prevention [2] - It is recommended that individuals over 40 undergo liver function tests every 1-2 years, while high-risk groups such as the obese, long-term drinkers, or those with chronic diseases should be screened annually [2] - For fatty liver patients, a weight loss of 5%-10% can significantly improve their condition; complete abstinence from alcohol is the only effective method for alcoholic liver disease [2] - Patients with hepatitis B and C should follow a structured antiviral treatment plan under medical guidance to achieve clinical cure [2]